节点文献

394例原发性肝癌的预后因素与疗效分析

Prognosis risk factors and therapeutic effect analysis in primary hepatic carcinoma: 394 cases report

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 孟志强刘鲁明马鑫林钧华陈震陈颢周振华王琨于尔辛

【Author】 MENG Zhi-qiang,LIU Lu-ming,MA Xin, LIN Jun-hua,CHEN Zhen, CHEN Hao, ZHOU Zhen-hua, WANG Kun, YU Er-xin (Deptartment of Integrative Oncology, Cancer Hospital, Fudan University,Department of Oncology,Shanghai Medical College, Fudan University, Shanghai 200032,China)

【机构】 复旦大学附属肿瘤医院中西医结合科 复旦大学上海医学院肿瘤学系复旦大学附属肿瘤医院中西医结合科复旦大学上海医学院肿瘤学系上海200032

【摘要】 背景与目的:肝癌是我国的高发恶性肿瘤,预后不佳,分析预后相关因素和选择合适的综合治疗是提高疗效的有效手段。本研究通过分析病理确诊的肝癌病例,以发现新的预后相关因素并分析不同治疗模式的疗效差异。方法:通过随访回顾性分析了394例病理确诊的原发性肝癌病例,利用Cox回归模型筛选有独立影响的预后因素。应用Kaplan-Meier方法计算生存率,分析评价各治疗手段的疗效。结果:根据国内临床分期标准,394例中Ⅱ期病例247例(62.69%),Ⅲ期病例88例(22.34%)。总的中位生存期为359d。1、2、3、5年生存期分别为49.39%、22.65%、13.64%和8.81%。Cox多因素分析显示对患者生存期有独立影响的因素包括:腹腔淋巴结转移、门脉癌栓、血清AKP、LDH、GGT水平和肝功能分级。疗效分析显示放疗、介入化疗栓塞和中草药等均能改善预后,综合治疗的疗效要好于单一治疗。其中介入化疗栓塞结合放疗和中草药的中位生存期达到472d。结论:腹腔淋巴结转移、门脉癌栓、血清AKP、LDH、GGT水平、肝功能分级是与预后相关的因素。综合治疗有利于疗效的提高,介入化疗栓塞结合放疗和中草药是较理想的综合治疗模式。

【Abstract】 Background and purpose:The incidence of primary liver cancer in China is high and has a poor prognosis. Analysis of the prognosis factors and the appropriate combined therapy is a way to improve the survival rate. The risk factors of pathologically diagnosed hepatic carcinoma cases were analyzed and the outcomes of different therapeutic patterns were compared in this article. Methods:We retrospectively studied 394 cases of primary hepatic carcinoma. The Cox regression model was used to find the factors which independently determined the prognosis. The survival rate was calculated and the outcome of different treatments using the Kaplan-Meier method was evaluated.Results:According to China (Guangzhou) Staging,59(14.97%) cases with stageⅠ,247 (62.69%) cases with stage Ⅱ and 88 (22.34%) cases with stage Ⅲ disease were analyzed. The median survival time was 359 days. The survival rates at 1, 2, 3 and 5 years were 49.39%, 22.65%, 13.64% and 8.81%, respectively. The Cox regression models indicated the independent factors determining the prognosis were: lymph nodes metastasis, portal vein thrombus, serum AKP, LDH, GGT level and Child-Pugh Staging. The treatments which include trans-catheter arterial chemoembolization (TACE), radiation therapy and traditional Chinese medicine improved the survival time. The median survival time implied that integrated therapy was better than single therapy treatment. For patients treated with TACE, radiation and traditional Chinese medicine, the median survival time was 472 days.Conclusions:Lymph node metastasis, portal vein thrombus, serum AKP, LDH, GGT level and Child-Pugh staging are the independent factors relevant to the prognosis of hepatocarcinoma. Integrated therapy is beneficial for improving therapeutic effect. The combined treatment with TACE, radiation and traditional Chinese medicine is a potential and promising treatment for advanced hepatic carcinoma.

  • 【文献出处】 中国癌症杂志 ,China Oncology , 编辑部邮箱 ,2007年08期
  • 【分类号】R735.7
  • 【被引频次】43
  • 【下载频次】609
节点文献中: 

本文链接的文献网络图示:

本文的引文网络